Literature DB >> 16076021

Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection.

Armen A Galoyan1, John S Sarkissian, Vergine A Chavushyan, Ruben M Sulkhanyan, Zaruhi E Avakyan, Zubeida A Avetisyan, Yuri Kh Grigorian, Davit O Abrahamyan.   

Abstract

The purpose of the present study was to evaluate the neuroprotective action of proline-rich peptide-1 (PRP-1) produced by hypothalamic nuclei cells (nuclei paraventricularis and supraopticus) following lateral hemisection of spinal cord (SC). The dynamics of rehabilitative shifts were investigated at various periods of postoperative survival (1-2, 3, and 4 weeks), both with administration of PRP-1 and without it (control). We registered evoked spike flow activity in both interneurons and motoneurons of the same segment of transected and symmetric intact sides of SC and below it on the stimulation of mixed (n. ischiadicus), flexor (n. gastrocnemius) and extensor (n. peroneus communis) nerves. In the control group (administration of 0.9% saline as placebo), no significant decrease of post-stimulus activity of neurons was observed on the transected side by the 2nd week. This activity strongly decreased by week 3 postaxotomy, with some increase on the intact side, possibly of compensatory origin. No shifts occurred by the 4th week. Regardless of the period of administration, PRP-1 increased neuronal activity on the transected side, with the same activation levels on both SC sides. These data were confirmed by histochemical investigation. PRP-1 administration, both daily and every other day, for a period of 2-3 weeks led to prevention of scar formation and promotion of the re-growth of white matter nerve fibers in the damaged area. It also resulted in prevention of neuroglial elements degeneration and reduction in gliosis expression in the lesion supporting neuronal survival. Thus, PRP-1 achieved protection against "tissue stress", which was also confirmed by the registration of activity on the level of transection and restoration of the motor activity on the injured side. The obtained data propose the possibility of PRP-1 application in clinical practice for prevention of neurodegeneration of traumatic origin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076021     DOI: 10.1007/s11064-005-2686-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  63 in total

1.  A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord.

Authors:  D W Huang; L McKerracher; P E Braun; S David
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  [Method for the demonstration of myelinated nerve fibers in the central nervous system].

Authors:  I B Meliksetian
Journal:  Morfologiia       Date:  2003

Review 3.  The Eph family receptors and ligands.

Authors:  R Zhou
Journal:  Pharmacol Ther       Date:  1998-03       Impact factor: 12.310

Review 4.  Functional plasticity of microglia: a review.

Authors:  W J Streit; M B Graeber; G W Kreutzberg
Journal:  Glia       Date:  1988       Impact factor: 7.452

Review 5.  Peptides in motoneurons.

Authors:  G Raivich; M Reddington; C A Haas; G W Kreutzberg
Journal:  Prog Brain Res       Date:  1995       Impact factor: 2.453

Review 6.  Trophic factors.

Authors:  T N Jelsma; A J Aguayo
Journal:  Curr Opin Neurobiol       Date:  1994-10       Impact factor: 6.627

7.  Induction of Eph B3 after spinal cord injury.

Authors:  J D Miranda; L A White; A E Marcillo; C A Willson; J Jagid; S R Whittemore
Journal:  Exp Neurol       Date:  1999-03       Impact factor: 5.330

8.  Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function.

Authors:  Y Liu; D Kim; B T Himes; S Y Chow; T Schallert; M Murray; A Tessler; I Fischer
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

9.  Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells.

Authors:  S Mansour-Robaey; D B Clarke; Y C Wang; G M Bray; A J Aguayo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading.

Authors:  P Caroni; M E Schwab
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

View more
  8 in total

1.  Protective effects of hypothalamic proline-rich peptide and cobra venom Naja Naja Oxiana on dynamics of vestibular compensation following unilateral labyrinthectomy.

Authors:  Armen A Galoyan; Naser Khalaji; Lilja E Hambardzumyan; Larisa P Manukyan; Irina B Meliksetyan; Vergine A Chavushyan; Vaghinak H Sarkisian; John S Sarkissian
Journal:  Neurochem Res       Date:  2010-08-12       Impact factor: 3.996

2.  Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.

Authors:  Karina A Galoian; Thomas H Temple; Armen Galoyan
Journal:  Tumour Biol       Date:  2011-04-15

3.  Effect of hypothalamic proline-rich peptide (PRP-1) on neuronal and bone marrow cell apoptosis.

Authors:  Armen A Galoyan; Josef Krieglstein; Susanne Klumpp; Kristina E Danielian; Karine A Galoian; Wolfram Kremers; Kristina B Bezirganyan; Tigran K Davtyan
Journal:  Neurochem Res       Date:  2007-06-05       Impact factor: 3.996

4.  Concepts of neuroendocrine cardiology and neuroendocrine immunology, chemistry and biology of signal molecules.

Authors:  Armen Galoyan
Journal:  Neurochem Res       Date:  2010-11-03       Impact factor: 3.996

5.  Hypothalamic proline rich polypeptide regulates hematopoiesis.

Authors:  Kristina B Bezirganyan; Tigran K Davtyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2009-12-18       Impact factor: 3.996

6.  Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.

Authors:  Karina Galoian; Thomas H Temple; Armen Galoyan
Journal:  Neurochem Res       Date:  2011-01-18       Impact factor: 3.996

7.  Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.

Authors:  Karina Galoian; Sean Scully; Armen Galoyan
Journal:  Neurochem Res       Date:  2008-07-09       Impact factor: 3.996

8.  Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.

Authors:  Karina Galoian; Sean Scully; George McNamara; Patrick Flynn; Armen Galoyan
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.